Developer docs
API playgroundTry for free, no card

Search company profiles

Cell Applications, Inc.

Full company profile

uuid000acjv

Namestring
Cell Applications, Inc.
Legal namestring
Cell Applications, Inc.
Company typeenum
Private
Founded yearint
1994
Descriptiontext

Cell Applications, Inc. is a privately held life-science tools company founded in 1994 and headquartered in San Diego, California, specializing in the isolation, characterization, and commercial supply of primary cells and supporting reagents for biomedical research. The company operates a cGMP-certified manufacturing facility and offers a catalog of more than 190 characterized primary cell types spanning eight species (human, rat, mouse, canine, porcine, bovine, rabbit, chicken) across roughly 30 tissue categories, including specialized cellular disease models for asthma, COPD, osteoarthritis, rheumatoid arthritis, Type 2 diabetes, and IBD. Its proprietary technology platform, DISCUS™, generates iPSC-derived 3D organoids — notably i-HH hepatocytes with sustained CYP3A4 metabolic activity and i-HAEpC2 alveolar epithelial cells — designed to address limitations of traditional 2D cultures and immortalized cell lines for chronic toxicity testing and disease modeling.

The company's product portfolio is organized around four core lines: Primary Cells, Media & Reagents (including over 30 cell type-specific optimized formulations), Cell Biology Products (antibodies, ELISA kits, growth factors, transfection reagents, RNA), and Organoids. Cell Applications generates revenue primarily through one-time catalog sales via its e-commerce website, with prices ranging from approximately $24 for basal media to $998 for individual cryovials of specialized cells such as human dendritic cells. Custom services — including primary cell isolation, cell-based assays, and 3D tissue/organoid development — are quoted on a per-project basis, and bulk media production in the cGMP facility is available in standard bottles or flexible bags for larger commercial customers.

Cell Applications serves three primary customer segments: academic and government research laboratories, biopharmaceutical and biotechnology companies (for drug discovery, DILI screening, and preclinical safety testing), and contract research organizations, with products distributed directly via the company website and through international distributor partnerships to researchers in over 40 countries. The company's offerings are cited in more than 4,000 peer-reviewed publications, supporting credibility with both academic buyers and pharmaceutical R&D procurement. Leadership comprises Dave Yu as Vice President of Business Development and Anna Wakeland as Director of Technical Sales; no additional management team data is publicly disclosed.

Short descriptiontext

Cell Applications, Inc. is a privately held San Diego-based life-science tools company founded in 1994 that supplies primary cells, cell type-specific media, and proprietary iPSC-derived 3D organoid platforms (DISCUS™) to academic researchers, biopharmaceutical companies, and CROs across more than 40 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
primary cell culture, life science reagents, cell biology media, iPSC-derived cells, organoid models
Industry4 codes
PRIMARYHLAAAIAJ
In Vitro Model Systems & Organoid Platforms (iPSC/organoids, microphysiological systems)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAAAGAD
Organoids & Organ-on-Chip (regenerative models)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAAABAH
Cell Processing & Ancillary Materials (media, cytokines, beads, vectors, disposables)
Healthcare & Life Sciences/Biotechnology & Biologics/Cell Therapy (autologous/allogeneic)
SECONDARYHLAAABAE
Stem Cell Therapies (MSC/iPSC/HSC-derived)
Healthcare & Life Sciences/Biotechnology & Biologics/Cell Therapy (autologous/allogeneic)
NAICS code2 codes
  • Biological Product (except Diagnostic) Manufacturing325414
  • Medical Equipment and Supplies Manufacturing3391
SIC code2 codes
  • Biological Products, (No Disgnostic Substances)2836
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
Product category
Cell Biology Reagents
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Primary Cell Sales
TypeOne Time License
Description

One-time sale of cryopreserved primary cells including human, animal (rat, mouse, canine, porcine, bovine, rabbit, chicken), and iPSC-derived cells. Cells are sold as cryovials, kits, proliferating cells in flasks, or multi-well plate formats. Revenue is generated per transaction with no recurring component.

cellapplications.com
2Media and Reagent Sales
TypeOne Time License
Description

Sale of cell type-specific growth media, basal media, supplements, freezing media, and subculture reagents. Products sold in various sizes (50ml, 100ml, 500ml) with kit options and individual component purchases. Supports ongoing research requiring consistent media supply.

cellapplications.com
3Cell Biology Products
TypeOne Time License
Description

Sale of supplementary products including antibodies, ELISA kits, growth factors, cytokines, transfection reagents, cell RNA, and tissue RNA for cell biology research applications.

cellapplications.com
4Custom Services
TypeProfessional Services
Description

Primary cell isolation services, cell-based assays, and 3D tissue/organoid custom solutions for specific research requirements.

cellapplications.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
Pricing details4 tiers
1Cryopreserved Cells - Individual Cryovials
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Standard cryopreserved cells sold as individual cryovials (typically 500,000-1,000,000 cells per vial). Example: Human Dendritic Cells at $998.00 per cryovial, Human Adipocytes pricing varies by format.

cellapplications.com
2Complete Cell Culture Kits
ModelUnit PricingBilling cadencePay-as-you-go
Notes

All-in-one kits combining cryopreserved cells, optimized growth medium, subculture reagent kit, and coated flasks. Examples: HFDPC Kit at various configurations, i-HH Total Kit with DISCUS system.

cellapplications.com
3Cell Media Products
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Ready-to-use media ($186-$197 per 500ml), basal media ($24-$97), supplement sets ($70-$197), and complete kits ($158-$162). Volume discounts may apply for larger orders.

cellapplications.com
4Custom and Bulk Orders
ModelOtherBilling cadenceMulti-year contract
Notes

Custom media formulation, large-scale media production in cGMP facility, and bulk cell orders require quote request. Available in standard bottles and flexible bags.

cellapplications.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Cell Applications, Inc. isolates, purifies, and supplies high-purity, low-passage primary cells from human and animal tissues, along with cell type-specific optimized growth media, culture reagents, and iPSC-derived 3D organoid products built on the proprietary DISCUS™ platform for life science research and pharmaceutical drug discovery. The company also provides custom services including primary cell isolation, cell-based assays, media formulation, and 3D tissue/organoid services, all produced in a cGMP-certified facility in San Diego, California.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • i-HH organoids maintain functional CYP3A4 activity and Phase I/II enzymes over multi-week culture windows, enabling chronic repeated-dose toxicity testing
+2 more records
Product overview1 text field

Cell Applications, Inc. is a recognized global leader in isolation and purification of Primary Cells and their culture in optimized, cell type-specific media. The company operates a cGMP-certified facility and offers a comprehensive portfolio organized around four core product lines: (1) Primary Cells — high purity, low passage human and animal cells from diverse tissues; (2) Media & Reagents — cell type-specific optimized culture media, freezing media, and culture reagents; (3) Cell Biology Products — antibodies, ELISA kits, growth factors, cytokines, transfection reagents, and RNA products; and (4) Organoids — iPSC-derived 3D tissue models using the proprietary DISCUS 3D technology platform. The portfolio also includes Cellular Disease Models for research applications and custom services for cell isolation, assay development, and media formulation.

Product and service11 records
1Primary Cells
CategoryPrimary Cells
Description

High-purity, low-passage primary cells isolated from a cGMP facility across human, rat, mouse, canine, porcine, bovine, rabbit, and chicken species, organized by cell type, tissue, species, and application for use in neuroscience, cardiovascular, stem cell biology, and regenerative medicine research.

2Media & Reagents
CategoryCell Culture Media and Reagents
Description

Cell type-specific optimized growth media, basal media, supplements, freezing media, subculture reagents, and media kits including serum-free, xeno-free, and animal-free options, available in 50ml, 100ml, and 500ml sizes.

3Cell Biology Products
CategoryCell Biology Products
Description

Supporting research products including antibodies, cell analysis tools, ELISA kits, growth factors, cytokines, and tissue RNA for cell biology research.

4Cellular Disease Models
CategoryDisease Models
Description

Pre-diseased and diseased primary cell models for Asthma, COPD, Osteoarthritis, Rheumatoid Arthritis, IBD, Type 2 Diabetes, and Plaque Psoriasis research applications.

5Organoids
Category3D Cell Culture and Organoids
Description

iPSC-derived 3D organoid models including i-HH hepatocytes and i-HAEpC2 alveolar epithelial cells using DISCUS 3D technology, producing polarized structures with bile canaliculi and supporting multiweek functional culture for chronic toxicity testing.

6Transfection Reagents
CategoryTransfection Reagents
Description

Transfection reagents including the Cytofect Epithelial Cell Transfection Kit for efficient gene delivery into primary cells.

7Stem Cells and iPSCs
CategoryStem Cell Products
Description

Human induced pluripotent stem cells (HiPSC) and iPSC-derived differentiated cells including hepatocytes, cardiac cells, neural stem cells, and brown fat preadipocytes for regenerative medicine and disease modeling.

8Cell RNA
CategoryMolecular Biology Reagents
Description

Total RNA prepared from various primary cell types for molecular biology research applications.

9DISCUS 3D System
CategoryTechnology Platform
Description

Proprietary 3D cell culture technology platform for generating organoids with polarized structures capable of multiweek culture, addressing challenges of anoxia and diffusion limits in 3D tissue engineering; offered as a kit (e.g., DISCUS 111 i-HH Gel Kit).

10Primary Cell Services
CategoryCustom Services
Description

Custom services including human and animal primary cell isolation, cell-based assays, and 3D tissue and organoid services tailored to specific research requirements.

11Cell Media Services
CategoryCustom Services
Description

Media formulation and optimization services plus large-scale media production in the cGMP facility, available in standard bottles and flexible bags for commercial quantities.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

German-based supplier of human primary cells, optimized media, and stem cell products with a comparable horizontal catalog spanning multiple tissue types and species — a direct alternative to Cell Applications' core catalog.

TypeDirect peer
Description

Global biological resource repository supplying primary cells, cell lines, and reagents to academic and pharma researchers; competes with Cell Applications in primary cell catalog depth and global distribution reach.

TypeBroad incumbent
Description

Large-scale cell therapy manufacturing, primary cells, and media; competes with Cell Applications on cell products, media supply, and now 3D/organoid services, but as part of a much broader CDMO portfolio.

TypeBroad incumbent
Description

Gibco-branded primary cells, media, and reagents from Thermo Fisher — a much larger incumbent whose bundled procurement and global logistics compete directly with Cell Applications' primary cell and media offerings.

TypeDirect peer
Description

Specializes in primary cells, stem cells, iPSC-derived products, and cell culture media with a research-tools catalog closely overlapping Cell Applications' horizontal offering.

TypeDirect peer
Description

Supplier of primary cells (adipocytes, hepatocytes, etc.) and cell-based assays for metabolic and dermatology research — a focused direct peer competing on primary cell catalog and custom services.

TypeEmerging player
Description

Provides primary cells, iPSC-derived cells, and custom cell-based assay services for drug discovery, overlapping with Cell Applications in primary cell supply and iPSC-based disease models.

8Corning Life Sciences
TypeBroad incumbent
Description

Major supplier of cell culture media, sera, and plasticware; competes with Cell Applications' media/reagent catalog as part of a much broader lab-consumables portfolio.

TypeBroad incumbent
Description

Supplies primary cells, iPSC-derived cells, media, and complementary reagents (growth factors, cytokines) — overlaps with Cell Applications across both cells and reagents.

TypeEmerging player
Description

GMP-manufactured cell culture reagents, media, and cytokines for cell therapy developers; comparable to Cell Applications' media and ancillary materials business with a stronger cell-therapy orientation.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cell Applications, Inc.

Cell Biology Reagentscellapplications.com

Cell Applications, Inc. is a privately held San Diego-based life-science tools company founded in 1994 that supplies primary cells, cell type-specific media, and proprietary iPSC-derived 3D organoid platforms (DISCUS™) to academic researchers, biopharmaceutical companies, and CROs across more than 40 countries.

What Cell Applications, Inc. does

Cell Applications, Inc. is a privately held life-science tools company founded in 1994 and headquartered in San Diego, California, specializing in the isolation, characterization, and commercial supply of primary cells and supporting reagents for biomedical research. The company operates a cGMP-certified manufacturing facility and offers a catalog of more than 190 characterized primary cell types spanning eight species (human, rat, mouse, canine, porcine, bovine, rabbit, chicken) across roughly 30 tissue categories, including specialized cellular disease models for asthma, COPD, osteoarthritis, rheumatoid arthritis, Type 2 diabetes, and IBD. Its proprietary technology platform, DISCUS™, generates iPSC-derived 3D organoids — notably i-HH hepatocytes with sustained CYP3A4 metabolic activity and i-HAEpC2 alveolar epithelial cells — designed to address limitations of traditional 2D cultures and immortalized cell lines for chronic toxicity testing and disease modeling.

The company's product portfolio is organized around four core lines: Primary Cells, Media & Reagents (including over 30 cell type-specific optimized formulations), Cell Biology Products (antibodies, ELISA kits, growth factors, transfection reagents, RNA), and Organoids. Cell Applications generates revenue primarily through one-time catalog sales via its e-commerce website, with prices ranging from approximately $24 for basal media to $998 for individual cryovials of specialized cells such as human dendritic cells. Custom services — including primary cell isolation, cell-based assays, and 3D tissue/organoid development — are quoted on a per-project basis, and bulk media production in the cGMP facility is available in standard bottles or flexible bags for larger commercial customers.

Cell Applications serves three primary customer segments: academic and government research laboratories, biopharmaceutical and biotechnology companies (for drug discovery, DILI screening, and preclinical safety testing), and contract research organizations, with products distributed directly via the company website and through international distributor partnerships to researchers in over 40 countries. The company's offerings are cited in more than 4,000 peer-reviewed publications, supporting credibility with both academic buyers and pharmaceutical R&D procurement. Leadership comprises Dave Yu as Vice President of Business Development and Anna Wakeland as Director of Technical Sales; no additional management team data is publicly disclosed.

Cell Applications, Inc. firmographics

Firmographics
Name
Cell Applications, Inc.
Legal name
Cell Applications, Inc.
Website
https://cellapplications.com
Company type
Private
Founded year
1994
Operating status
Operating
Headcount range
11–50 employees
Short description
Cell Applications, Inc. is a privately held San Diego-based life-science tools company founded in 1994 that supplies primary cells, cell type-specific media, and proprietary iPSC-derived 3D organoid platforms (DISCUS™) to academic researchers, biopharmaceutical companies, and CROs across more than 40 countries.
Ownership category
akta.pro rank

Cell Applications, Inc. industry classification

Industry
Product category
Cell Biology Reagents
NAICS
Biological Product (except Diagnostic) Manufacturing (325414), Medical Equipment and Supplies Manufacturing (3391)
SIC
Biological Products, (No Disgnostic Substances) (2836), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
akta.pro industry
PRIMARYHLAAAIAJ
In Vitro Model Systems & Organoid Platforms (iPSC/organoids, microphysiological systems)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAAAGAD
Organoids & Organ-on-Chip (regenerative models)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAAABAH
Cell Processing & Ancillary Materials (media, cytokines, beads, vectors, disposables)
Healthcare & Life Sciences/Biotechnology & Biologics/Cell Therapy (autologous/allogeneic)
SECONDARYHLAAABAE
Stem Cell Therapies (MSC/iPSC/HSC-derived)
Healthcare & Life Sciences/Biotechnology & Biologics/Cell Therapy (autologous/allogeneic)

Keywords

  • Primary cell culture
  • Life science reagents
  • Cell biology media
  • IPSC-derived cells
  • Organoid models

Where Cell Applications, Inc. is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Cell Applications, Inc. business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

  1. Primary Cell Sales: One-time sale of cryopreserved primary cells including human, animal (rat, mouse, canine, porcine, bovine, rabbit, chicken), and iPSC-derived cells. Cells are sold as cryovials, kits, proliferating cells in flasks, or multi-well plate formats. Revenue is generated per transaction with no recurring component.
  2. Media and Reagent Sales: Sale of cell type-specific growth media, basal media, supplements, freezing media, and subculture reagents. Products sold in various sizes (50ml, 100ml, 500ml) with kit options and individual component purchases. Supports ongoing research requiring consistent media supply.
  3. Cell Biology Products: Sale of supplementary products including antibodies, ELISA kits, growth factors, cytokines, transfection reagents, cell RNA, and tissue RNA for cell biology research applications.
  4. Custom Services: Primary cell isolation services, cell-based assays, and 3D tissue/organoid custom solutions for specific research requirements.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goCryopreserved Cells - Individual Cryovials
Unit PricingPay-as-you-goComplete Cell Culture Kits
Unit PricingPay-as-you-goCell Media Products
OtherMulti-year contractCustom and Bulk Orders

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Cell Applications, Inc. product offering

Product offering

Core offering

Cell Applications, Inc. isolates, purifies, and supplies high-purity, low-passage primary cells from human and animal tissues, along with cell type-specific optimized growth media, culture reagents, and iPSC-derived 3D organoid products built on the proprietary DISCUS™ platform for life science research and pharmaceutical drug discovery. The company also provides custom services including primary cell isolation, cell-based assays, media formulation, and 3D tissue/organoid services, all produced in a cGMP-certified facility in San Diego, California.

Product overview

Cell Applications, Inc. is a recognized global leader in isolation and purification of Primary Cells and their culture in optimized, cell type-specific media. The company operates a cGMP-certified facility and offers a comprehensive portfolio organized around four core product lines: (1) Primary Cells — high purity, low passage human and animal cells from diverse tissues; (2) Media & Reagents — cell type-specific optimized culture media, freezing media, and culture reagents; (3) Cell Biology Products — antibodies, ELISA kits, growth factors, cytokines, transfection reagents, and RNA products; and (4) Organoids — iPSC-derived 3D tissue models using the proprietary DISCUS 3D technology platform. The portfolio also includes Cellular Disease Models for research applications and custom services for cell isolation, assay development, and media formulation.

Differentiator

Problem solved

Functional benefit

Products and services

  • Primary Cells High-purity, low-passage primary cells isolated from a cGMP facility across human, rat, mouse, canine, porcine, bovine, rabbit, and chicken species, organized by cell type, tissue, species, and application for use in neuroscience, cardiovascular, stem cell biology, and regenerative medicine research.
  • Media & Reagents Cell type-specific optimized growth media, basal media, supplements, freezing media, subculture reagents, and media kits including serum-free, xeno-free, and animal-free options, available in 50ml, 100ml, and 500ml sizes.
  • Cell Biology Products Supporting research products including antibodies, cell analysis tools, ELISA kits, growth factors, cytokines, and tissue RNA for cell biology research.
  • Cellular Disease Models Pre-diseased and diseased primary cell models for Asthma, COPD, Osteoarthritis, Rheumatoid Arthritis, IBD, Type 2 Diabetes, and Plaque Psoriasis research applications.
  • Organoids iPSC-derived 3D organoid models including i-HH hepatocytes and i-HAEpC2 alveolar epithelial cells using DISCUS 3D technology, producing polarized structures with bile canaliculi and supporting multiweek functional culture for chronic toxicity testing.
  • Transfection Reagents Transfection reagents including the Cytofect Epithelial Cell Transfection Kit for efficient gene delivery into primary cells.
  • Stem Cells and iPSCs Human induced pluripotent stem cells (HiPSC) and iPSC-derived differentiated cells including hepatocytes, cardiac cells, neural stem cells, and brown fat preadipocytes for regenerative medicine and disease modeling.
  • Cell RNA Total RNA prepared from various primary cell types for molecular biology research applications.
  • DISCUS 3D System Proprietary 3D cell culture technology platform for generating organoids with polarized structures capable of multiweek culture, addressing challenges of anoxia and diffusion limits in 3D tissue engineering; offered as a kit (e.g., DISCUS 111 i-HH Gel Kit).
  • Primary Cell Services Custom services including human and animal primary cell isolation, cell-based assays, and 3D tissue and organoid services tailored to specific research requirements.
  • Cell Media Services Media formulation and optimization services plus large-scale media production in the cGMP facility, available in standard bottles and flexible bags for commercial quantities.

Quantifiable outcome

  • i-HH organoids maintain functional CYP3A4 activity and Phase I/II enzymes over multi-week culture windows, enabling chronic repeated-dose toxicity testing
  • +2 more outcomes

Companies that use Cell Applications, Inc.

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Cell Applications, Inc. technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Cell Applications, Inc. partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Cell Applications, Inc. competitors and assessment

Company assessment

Direct peers

  • PromoCell: German-based supplier of human primary cells, optimized media, and stem cell products with a comparable horizontal catalog spanning multiple tissue types and species — a direct alternative to Cell Applications' core catalog.
  • ATCC: Global biological resource repository supplying primary cells, cell lines, and reagents to academic and pharma researchers; competes with Cell Applications in primary cell catalog depth and global distribution reach.
  • STEMCELL Technologies: Specializes in primary cells, stem cells, iPSC-derived products, and cell culture media with a research-tools catalog closely overlapping Cell Applications' horizontal offering.
  • ZenBio: Supplier of primary cells (adipocytes, hepatocytes, etc.) and cell-based assays for metabolic and dermatology research — a focused direct peer competing on primary cell catalog and custom services.

Broad incumbents

  • Lonza: Large-scale cell therapy manufacturing, primary cells, and media; competes with Cell Applications on cell products, media supply, and now 3D/organoid services, but as part of a much broader CDMO portfolio.
  • Thermo Fisher Scientific (Gibco): Gibco-branded primary cells, media, and reagents from Thermo Fisher — a much larger incumbent whose bundled procurement and global logistics compete directly with Cell Applications' primary cell and media offerings.
  • Corning Life Sciences: Major supplier of cell culture media, sera, and plasticware; competes with Cell Applications' media/reagent catalog as part of a much broader lab-consumables portfolio.
  • Bio-Techne (R&D Systems): Supplies primary cells, iPSC-derived cells, media, and complementary reagents (growth factors, cytokines) — overlaps with Cell Applications across both cells and reagents.

Emerging players

  • iXCells Biotechnologies: Provides primary cells, iPSC-derived cells, and custom cell-based assay services for drug discovery, overlapping with Cell Applications in primary cell supply and iPSC-based disease models.
  • CellGenix: GMP-manufactured cell culture reagents, media, and cytokines for cell therapy developers; comparable to Cell Applications' media and ancillary materials business with a stronger cell-therapy orientation.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Cell Applications, Inc. social profiles

Digital presence

Cell Applications, Inc. compliance and trust

Trust signal

Compliance1 record

Cell Applications, Inc. financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cell Applications, Inc. leadership team

Management profile

Number of profiles

Profiles2 records

Cell Applications, Inc. funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cell Applications, Inc. M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cell Applications, Inc.

What does Cell Applications, Inc. do?

Cell Applications, Inc. isolates, purifies, and supplies high-purity, low-passage primary cells from human and animal tissues, along with cell type-specific optimized growth media, culture reagents, and iPSC-derived 3D organoid products built on the proprietary DISCUS™ platform for life science research and pharmaceutical drug discovery. The company also provides custom services including primary cell isolation, cell-based assays, media formulation, and 3D tissue/organoid services, all produced in a cGMP-certified facility in San Diego, California.

Is Cell Applications, Inc. a public or private company?

Cell Applications, Inc. is a private company. It is classified as unknown and is currently operating.

When was Cell Applications, Inc. founded?

Cell Applications, Inc. was founded in 1994. It employs 11 to 50 people.

Where is Cell Applications, Inc. based?

Cell Applications, Inc. is headquartered in San Diego, United States, in the North America region.

How does Cell Applications, Inc. make money?

Four revenue lines are on record. Primary Cell Sales are the primary driver. The others are media and Reagent Sales, cell Biology Products and custom Services.

Who are Cell Applications, Inc.'s main competitors?

Direct peers on record are PromoCell, ATCC, STEMCELL Technologies and ZenBio. Broad incumbents are Lonza, Thermo Fisher Scientific (Gibco), Corning Life Sciences and Bio-Techne (R&D Systems). Emerging players are iXCells Biotechnologies and CellGenix.

Does Cell Applications, Inc. have an API?

No public API is recorded for Cell Applications, Inc..

What industry is Cell Applications, Inc. in?

Cell Applications, Inc.'s product category is Cell Biology Reagents. Its primary akta.pro industry code is HLAAAIAJ, In Vitro Model Systems & Organoid Platforms (iPSC/organoids, microphysiological systems), with a secondary code of HLAAAGAD, Organoids & Organ-on-Chip (regenerative models). Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Global Market Insights Inc.Mesenchymal Stem Cells Market StatisticsThe mesenchymal stem cells market was valued at USD 3 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 12.8% to reach approximately USD 10.3 billion by 2032, driven by the increasing prevalence of chronic diseases and applications in regenerative medicine. Key players involved in this market include Thermo Fisher Scientific, Cell Applications, and Cyagen Biosciences, among others. The pandemic has also highlighted the therapeutic potential of mesenchymal stem cells in treating COVID-19 complications, leading to increased investment in research and development in this area.Market ScoopMesenchymal Stem Cells MarketThe Mesenchymal Stem Cells market is projected to reach approximately USD 10 billion by 2033, growing from USD 3 billion in 2023 at a CAGR of 12.6%. This growth is driven by increased research into MSC applications in regenerative medicine, with significant market participation from companies like Mesoblast Limited and Pluristem Therapeutics focusing on innovative MSC-based products. The landscape is influenced by emerging trends like AI integration and the evolving understanding of MSC therapies.Cell ApplicationsAirway Cells Breathe Life into Lung ResearchCell Applications added Human Small Airway Epithelial Cells and optimized media to its lung cell portfolio. The cells support research on respiratory diseases like asthma, COPD, and cystic fibrosis, and are available as cryopreserved kits or fresh cells.CNBCSoon printing a human heart on demand will no longer be sci-fiCyfuse Biomedical has bioprinted blood vessels and transplanted neural tissue into a small animal's brain, with a cartilage trial underway. The regenerative medicine market is projected to reach $101.3 billion by 2022, and Japan forecasts $9.6 billion domestically by 2030.Cell ApplicationsCategory: Stem Cells and iPSCsCell Applications, Inc. offers induced pluripotent stem cells, hematopoietic progenitor cells, neural and mesenchymal stem cells, and human dermal fibroblasts. The company plans additional stem cell offerings soon, and Persistence Market Research lists it as a major player in the global stem cell market.PR NewswireNew Scaffold-Free 3D Bioprinting Method Available to Researchers for First Time in North AmericaCell Applications, Inc. and Cyfuse Biomedical K.K. announced the availability of scaffold-free 3D bioprinting services in North America using the Kenzan Method and Regenova® 3D Bio Printer. This partnership marks the first deployment of this technology outside Japan, allowing researchers in the U.S. and Canada to access customized tissue engineering solutions for drug discovery and regenerative medicine.Cell ApplicationsCategory: Primary CellsCAI offers a catalog of high-purity, low-passage primary cells from its cGMP facility, covering neuroscience, cardiovascular, muscular, skeletal, skin, and epithelial/endothelial types. The catalog is organized by cell type, tissue, or species for research applications.Cell ApplicationsSuperior Neuron CultureCell Applications' optimized medium for rat dorsal root ganglion neurons shows superior viability and neurite extensions compared to a competitor's medium. The comparison was made at 1×10^5 cells/cm2, with images from days 1, 2, and 7. This could enhance CNS research and development.Cell ApplicationsCAI Certified for cGMPUL issued certificate #15-172954-1 to Cell Applications, Inc. for its CAI management system, certifying conformance to FDA 21 CFR Part 820 cGMP for manufacturing and packaging of cell culture media. The audit covered records, statistical techniques, and controls for process, design, production, labeling, packaging, documentation, and purchasing.Cell ApplicationsMacrophages & Microglia AddedCell Applications added rat macrophages and microglia cells to its Primary Blood Cell lineup, available cryopreserved or in kits with culture media. The cells are used to research inflammation, wound healing, metastasis, and neuro-inflammation, enhancing studies on normal physiology and diseases.